#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3428	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2383	421.2	0	.	n	.	0	A69G	SNP	69	69	A	530	530	G	522	G,A,T	311,118,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3428	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2383	421.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1911	1911	T	485	T,A,G	402,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3428	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2383	421.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1645	1645	C	536	C,T,A	440,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3428	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2383	421.2	0	HET	.	.	.	C207T	.	207	207	C	668	668	C	468	C,T	257,104	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5726	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3882	440.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1892	1892	A	484	A,C,T	400,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5726	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3882	440.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2526	2526	C	533	C,A,T	424,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5726	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3882	440.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2600	2600	A	583	A,C	441,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5726	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3882	440.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3152	3152	C	496	C,A,T	383,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	484	folP	852	852	99.88	folP.l15.c4.ctg.1	1821	79.2	0	.	p	.	0	E151K	NONSYN	451	453	GAA	968	970	AAA	101;100;102	A,T;A;A	78,2;83;79	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	484	folP	852	852	99.88	folP.l15.c4.ctg.1	1821	79.2	1	SNP	p	R228S	1	.	.	682	684	AGC	1199	1201	AGC	106;106;105	A,G;G;C	84,1;84;84	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1188	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3578	99.3	1	SNP	p	S91F	0	.	.	271	273	TCC	689	691	TCC	109;109;109	T;C;C	87;88;92	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1188	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3578	99.3	1	SNP	p	D95N	0	.	.	283	285	GAC	701	703	GAC	110;111;111	G;A;C	90;87;91	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1188	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3578	99.3	1	SNP	p	D95G	0	.	.	283	285	GAC	701	703	GAC	110;111;111	G;A;C	90;87;91	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	532	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1571	100.6	1	SNP	p	G45D	0	.	.	133	135	GGC	588	590	GGC	158;158;160	G,T;G,A;C,A,T	128,1;126,1;123,1,1	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	290	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1301	66.2	0	.	n	.	0	A197.	DEL	197	197	A	704	704	A	125	A	100	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1168	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3349	104.3	1	SNP	p	D86N	0	.	.	256	258	GAC	731	733	GAC	130;130;130	G;A,C,T;C,T	99;99,1,1;108,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1168	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3349	104.3	1	SNP	p	S87W	0	.	.	259	261	AGT	734	736	AGT	128;128;128	A;G;T	100;107;105	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1168	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3349	104.3	1	SNP	p	S87I	0	.	.	259	261	AGT	734	736	AGT	128;128;128	A;G;T	100;107;105	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1168	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3349	104.3	1	SNP	p	S87R	0	.	.	259	261	AGT	734	736	AGT	128;128;128	A;G;T	100;107;105	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1168	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3349	104.3	1	SNP	p	S88P	0	.	.	262	264	TCC	737	739	TCC	128;127;127	T,C;C;C	100,1;104;103	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	916	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2882	94.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1654	1656	GGC	117;117;116	G;G;C,G	89;87;86,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	910	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	107.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1295	1297	GCA	154;154;155	G,A;C,T,A;A	123,1;122,1,1;124	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	910	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	107.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1298	1300	ATC	156;156;155	A;T;C	123;126;125	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	910	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	107.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1310	1312	GTG	151;151;153	G;T;G	121;125;123	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	910	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	107.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1310	1312	GTG	151;151;153	G;T;G	121;125;123	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	910	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	107.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1814	1816	ACC	103;103;104	A;C;C,G	85;89;88,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	910	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	107.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1868	1870	GCG	106;105;106	G;C;G,T	89;76;75,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	910	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	107.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1868	1870	GCG	106;105;106	G;C;G,T	89;76;75,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	910	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	107.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1991	1993	GGC	113;113;112	G,C;G;C	89,1;89;89	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	910	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	107.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2000	2002	GGC	115;114;115	G,A;G,C,A;C,T	86,1;83,1,1;86,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	910	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2527	107.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2018	2020	CTG	117;116;119	C;T;G	87;87;89	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1286	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3238	118.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1665	1667	CCG	96;98;99	C,T;C,A;G	68,1;72,1;76	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	564	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2145	78.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	720	720	C	68	C	56	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	746	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2002	109.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	660	662	GAA	159;160;160	G;A;A,G	119;119;122,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	746	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2002	109.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	948	950	GAT	137;137;137	G;A;T	107;107;110	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	746	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2002	109.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1071	1073	TCA	152;153;154	T;C;A	116;123;126	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	746	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2002	109.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1200	1202	GTC	151;152;152	G,A;T;C	124,1;127;128	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	746	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2002	109.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1212	1214	TCT	156;156;158	T,A;C,A;T	130,1;128,1;130	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	746	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2002	109.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1530	1532	GCA	172;171;170	G;C;A	139;131;131	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	746	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2002	109.8	1	SNP	p	G120K	1	.	.	358	360	AAG	906	908	AAG	146;146;147	A;A;G	108;111;115	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	746	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2002	109.8	1	SNP	p	D121N	0	.	.	361	363	GAC	909	911	GAC	147;147;147	G;A;C	113;117;117	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	746	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	2002	109.8	1	SNP	p	A121D	1	.	.	361	363	GAC	909	911	GAC	147;147;147	G;A;C	113;117;117	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2528	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5351	141.4	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2237	2239	AAT	134;135;135	A;A;T	107;111;104	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	356	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1292	82.4	1	SNP	p	V57M	1	.	.	169	171	ATG	685	687	ATG	154;154;154	A,T;T;G	120,1;122;124	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
